229 related articles for article (PubMed ID: 21926944)
1. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
[TBL] [Abstract][Full Text] [Related]
2. Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network.
Lablanche S; Borot S; Wojtusciszyn A; Bayle F; Tétaz R; Badet L; Thivolet C; Morelon E; Frimat L; Penfornis A; Kessler L; Brault C; Colin C; Tauveron I; Bosco D; Berney T; Benhamou PY;
Diabetes Care; 2015 Sep; 38(9):1714-22. PubMed ID: 26068866
[TBL] [Abstract][Full Text] [Related]
3. Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival.
Deng S; Markmann JF; Rickels M; Yeh H; Kim JI; Lian MM; Gu Y; Markmann E; Palanjian M; Barker CF; Naji A
Transplantation; 2009 Sep; 88(6):820-5. PubMed ID: 19920782
[TBL] [Abstract][Full Text] [Related]
4. Primary graft function, metabolic control, and graft survival after islet transplantation.
Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
[TBL] [Abstract][Full Text] [Related]
5. Influence of islet transportation on pancreatic islet allotransplantation in type 1 diabetic patients within the Swiss-French GRAGIL network.
Kessler L; Bucher P; Milliat-Guittard L; Benhamou PY; Berney T; Penfornis A; Badet L; Thivolet C; Bayle F; Oberholzer J; Renoult E; Brun MJ; Rifle G; Atlan C; Colin C; Morel P;
Transplantation; 2004 Apr; 77(8):1301-4. PubMed ID: 15114103
[TBL] [Abstract][Full Text] [Related]
6. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
Lablanche S; Vantyghem MC; Kessler L; Wojtusciszyn A; Borot S; Thivolet C; Girerd S; Bosco D; Bosson JL; Colin C; Tetaz R; Logerot S; Kerr-Conte J; Renard E; Penfornis A; Morelon E; Buron F; Skaare K; Grguric G; Camillo-Brault C; Egelhofer H; Benomar K; Badet L; Berney T; Pattou F; Benhamou PY;
Lancet Diabetes Endocrinol; 2018 Jul; 6(7):527-537. PubMed ID: 29776895
[TBL] [Abstract][Full Text] [Related]
7. Five-year follow-up after clinical islet transplantation.
Ryan EA; Paty BW; Senior PA; Bigam D; Alfadhli E; Kneteman NM; Lakey JR; Shapiro AM
Diabetes; 2005 Jul; 54(7):2060-9. PubMed ID: 15983207
[TBL] [Abstract][Full Text] [Related]
8. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.
Keymeulen B; Ling Z; Gorus FK; Delvaux G; Bouwens L; Grupping A; Hendrieckx C; Pipeleers-Marichal M; Van Schravendijk C; Salmela K; Pipeleers DG
Diabetologia; 1998 Apr; 41(4):452-9. PubMed ID: 9562350
[TBL] [Abstract][Full Text] [Related]
9. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.
Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Boyle PJ; Falqui L; Marchetti P; Ricordi C; Gingerich RL
Transplantation; 1991 Jan; 51(1):76-85. PubMed ID: 1987709
[TBL] [Abstract][Full Text] [Related]
10. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
Chetboun M; Drumez E; Ballou C; Maanaoui M; Payne E; Barton F; Kerr-Conte J; Vantyghem MC; Piemonti L; Rickels MR; Labreuche J; Pattou F;
Lancet Diabetes Endocrinol; 2023 Jun; 11(6):391-401. PubMed ID: 37105208
[TBL] [Abstract][Full Text] [Related]
11. Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients.
Koh A; Imes S; Kin T; Dinyari P; Malcolm A; Toso C; Shapiro AM; Senior P
Transplantation; 2010 Feb; 89(3):361-5. PubMed ID: 20145529
[TBL] [Abstract][Full Text] [Related]
12. Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000). Groupe de Recherche Rhin Rhĵne Alpes Genève pour la transplantation d'Ilots de Langerhans.
Benhamou PY; Oberholzer J; Toso C; Kessler L; Penfornis A; Bayle F; Thivolet C; Martin X; Ris F; Badet L; Colin C; Morel P;
Diabetologia; 2001 Jul; 44(7):859-64. PubMed ID: 11508270
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada.
Marfil-Garza BA; Imes S; Verhoeff K; Hefler J; Lam A; Dajani K; Anderson B; O'Gorman D; Kin T; Bigam D; Senior PA; Shapiro AMJ
Lancet Diabetes Endocrinol; 2022 Jul; 10(7):519-532. PubMed ID: 35588757
[TBL] [Abstract][Full Text] [Related]
14. Successful islet transplantation: continued insulin reserve provides long-term glycemic control.
Ryan EA; Lakey JR; Paty BW; Imes S; Korbutt GS; Kneteman NM; Bigam D; Rajotte RV; Shapiro AM
Diabetes; 2002 Jul; 51(7):2148-57. PubMed ID: 12086945
[TBL] [Abstract][Full Text] [Related]
15. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.
Froud T; Baidal DA; Faradji R; Cure P; Mineo D; Selvaggi G; Kenyon NS; Ricordi C; Alejandro R
Transplantation; 2008 Dec; 86(12):1695-701. PubMed ID: 19104407
[TBL] [Abstract][Full Text] [Related]
16. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
[TBL] [Abstract][Full Text] [Related]
17. Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial.
Badet L; Benhamou PY; Wojtusciszyn A; Baertschiger R; Milliat-Guittard L; Kessler L; Penfornis A; Thivolet C; Renard E; Bosco D; Morel P; Morelon E; Bayle F; Colin C; Berney T;
Transplantation; 2007 Jul; 84(1):89-96. PubMed ID: 17627243
[TBL] [Abstract][Full Text] [Related]
18. Long-term function (6 years) of islet allografts in type 1 diabetes.
Alejandro R; Lehmann R; Ricordi C; Kenyon NS; Angelico MC; Burke G; Esquenazi V; Nery J; Betancourt AE; Kong SS; Miller J; Mintz DH
Diabetes; 1997 Dec; 46(12):1983-9. PubMed ID: 9392484
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
[TBL] [Abstract][Full Text] [Related]
20. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
